Abstract
The current pandemic caused by the coronavirus SARS-CoV-2 is having negative health, social and economic consequences worldwide. In Europe, the pandemic started to develop strongly at the end of February and beginning of March 2020. It has subsequently spread over the continent, with special virulence in northern Italy and inland Spain. In this study we show that an unusual persistent anticyclonic situation prevailing in southwestern Europe during February 2020 (i.e. anomalously strong positive phase of the North Atlantic and Arctic Oscillations) could have resulted in favorable conditions, in terms of air temperature and humidity, in Italy and Spain for a quicker spread of the virus compared with the rest of the European countries. It seems plausible that the strong atmospheric stability and associated dry conditions that dominated in these regions may have favored the virus’s propagation, by short-range droplet transmission as well as likely by long-range aerosol (airborne) transmission.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
A. Sanchez-Lorenzo was supported by a fellowship RYC-2016–20784 funded by the Ministry of Science and Innovation. Javier Vaquero-Martinez was supported by a predoctoral fellowship (PD18029) from Junta de Extremadura and European Social Fund. J.A. Lopez-Bustins was supported by Climatology Group of the University of Barcelona (2017 SGR 1362, Catalan Government) and the CLICES project (CGL2017-83866-C3-2-R, AEI/FEDER, UE). This research was supported by the Economy and Infrastructure Counselling of the Junta of Extremadura through grant GR18097 (co-financed by the European Regional Development Fund). J. Vázquez, Xavi B. and Raúl J.I. (UPV/EHU) kindly helped us in discussing the results. NCEP Reanalysis data provided by the NOAA/OAR/ESRL PSL, Boulder, Colorado, USA, from their Web site at https://psl.noaa.gov/
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets generated during the current study are available from the corresponding author on reasonable request and in the printed version of the manuscript.
